Core Insights - The conference focused on infertility prevention and treatment strategies, emphasizing the innovative application of traditional Chinese medicine (TCM) in reproductive health [1][3][5] Group 1: Conference Overview - The second academic annual meeting and expert tour on infertility and reproductive health was successfully held in Chengdu, organized by the China Medical Education Association and supported by Good Doctor Group and Shenyang Qinggong Pharmaceutical Group [1] - The event gathered renowned experts, scholars, and clinicians in the field of TCM and reproductive health to share authoritative reports, specialized discussions, and practical case studies [1] Group 2: Keynote Highlights - Huang Zhengming, Honorary President of the China Medical Education Association, emphasized the importance of grassroots TCM revitalization and the integration of TCM and Western medicine to address reproductive health challenges [3] - The meeting outlined three strategic actions: strengthening grassroots talent through new expert committee members, honoring frontline doctors as "guardians of health," and promoting specialized courses on infertility to enhance technical capabilities [3] Group 3: Expert Contributions - Huang Zhengming analyzed the dynamic changes in China's fertility rate, discussing the direct impact of contemporary social phenomena on reproductive willingness [5] - Wang Zheng, Vice Chairman of the Health and Medicine Committee of the Chinese People's Political Consultative Conference, highlighted TCM's unique advantages in regulating menstruation and improving endometrial receptivity, advocating for a collaborative approach between TCM and Western medicine [5] Group 4: Initiatives and Future Plans - The Good Doctor Group announced the launch of the "Infertility Reproductive Health Expert Tour" in April 2024, which has already assisted over 5,000 families in overcoming fertility challenges [5] - Aiming for long-term development, the Good Doctor Group plans to establish a "China Reproductive Health Industry Base" centered around Shenyang Qinggong Pharmaceutical, integrating TCM heritage with cutting-edge technology to enhance training and resource allocation for grassroots doctors [5] Group 5: Consensus and Goals - The conference reached a consensus on enhancing reproductive health service levels, contributing to national population strategies, and supporting the "Healthy China 2030" initiative [7]